Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/0929867324666161118125827PMID 27855621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis

  2016cited by this paper
• The multiple facets of alpha-1-antitrypsin.

  2015cited by this paper
• Lung Transplantation in Alpha-1-Antitrypsin Deficiency

  2015cited by this paper
• Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles

  2015cited by this paper
• SERPINA1 Full-Gene Sequencing Identifies Rare Mutations Not Detected in Targeted Mutation Analysis.

  2015cited by this paper
• How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

  2015cited by this paper
• PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD

  2015cited by this paper
• The Impact of Smoke Exposure on the Clinical Phenotype of Alpha-1 Antitrypsin Deficiency in Ireland: Exploiting a National Registry to Understand a Rare Disease

  2015cited by this paper
• Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction

  2015cited by this paper
• Clinical heterogeneity and potential high pathogenicity of the Mmalton Alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states

  2015cited by this paper
• Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency

  2015cited by this paper
• Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals

  2015cited by this paper
• Relationship between Change in Lung Density and Long-Term Progression of Lung Function.

  2015cited by this paper
• Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.

  2015cited by this paper
• Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls

  2014cited by this paper
• The Circulating Proteinase Inhibitor α-1 Antitrypsin Regulates Neutrophil Degranulation and Autoimmunity

  2014cited by this paper
• Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid

  2014cited by this paper
• Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

  2014cited by this paper
• Identification and characterisation of eight novel SERPINA1 Null mutations

  2014cited by this paper
• One- to Four-Year Follow-Up of Endobronchial Lung Volume Reduction in Alpha-1-Antitrypsin Deficiency Patients: A Case Series

  2014cited by this paper
• Disease associations in alpha-1-antitrypsin deficiency.

  2014cited by this paper
• The molecular and cellular pathology of α₁-antitrypsin deficiency.

  2014cited by this paper
• Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy.

  2013cited by this paper
• Distinguishing alpha1-antitrypsin deficiency from asthma.

  2013cited by this paper
• The Electrophoretic α1-Globulin Pattern of Serum in α1-Antitrypsin Deficiency

  2013cited by this paper
• α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α.

  2013cited by this paper
• Is There a Therapeutic Role for Selenium in Alpha-1 Antitrypsin Deficiency?

  2013cited by this paper
• Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy

  2012cited by this paper
• Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review

  2012cited by this paper
• Three New Alpha1-Antitrypsin Deficiency Variants Help to Define a C-Terminal Region Regulating Conformational Change and Polymerization

  2012cited by this paper
• Structural Dynamics Associated with Intermediate Formation in an Archetypal Conformational Disease

  2012cited by this paper
• Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry.

  2011cited by this paper
• Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema

  2011cited by this paper
• Alpha-1-Antitrypsin Deficiency in Early Childhood

  2011cited by this paper
• Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury.

  2011cited by this paper
• Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres

  2010cited by this paper
• Outdoor air pollution is associated with rapid decline of lung function in α-1-antitrypsin deficiency

  2010cited by this paper
• A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with α1‐antitrypsin deficiency

  2010cited by this paper
• α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8.

  2010cited by this paper
• An Autophagy-Enhancing Drug Promotes Degradation of Mutant α1-Antitrypsin Z and Reduces Hepatic Fibrosis

  2010cited by this paper
• Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry

  2010cited by this paper
• Lung deposition of inhaled Alpha-1-proteinase inhibitor (Alpha1-PI) - problems and experience of Alpha1-PI inhalation therapy in patients with hereditary Alpha1-PI deficiency and cystic fibrosis

  2010cited by this paper
• An overview of salsalate as a potential antidiabetic therapy.

  2010cited by this paper
• α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.

  2010cited by this paper
• Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients

  2010cited by this paper
• CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency.

  2009cited by this paper
• Outdoor air pollution is associated with disease severity in α1-antitrypsin deficiency

  2009cited by this paper
• Molecular characterization of the new defective Pbrescia alpha1‐antitrypsin allele

  2009cited by this paper
• Selenoprotein S/SEPS1 Modifies Endoplasmic Reticulum Stress in Z Variant α1-Antitrypsin Deficiency*

  2009cited by this paper
• New Findings in PiZZ α1-Antitrypsin Deficiency-Related Panniculitis

  2009cited by this paper
• Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha1-antitrypsin.

  2009cited by this paper
• alpha1-Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies.

  2009cited by this paper
• Influenza vaccination in subjects with alpha1-antitrypsin deficiency.

  2008cited by this paper
• The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus

  2008cited by this paper
• SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations.

  2008cited by this paper
• Inherited chronic obstructive pulmonary disease: new selective-sequencing workup for alpha1-antitrypsin deficiency identifies 2 previously unidentified null alleles.

  2008cited by this paper
• Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated mice.

  2007cited by this paper
• Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages

  2007cited by this paper
• In vivo post-transcriptional gene silencing of α-1 antitrypsin by adeno-associated virus vectors expressing siRNA

  2007cited by this paper
• Alpha‐1‐antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model

  2007cited by this paper
• A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells

  2007cited by this paper
• The pathogenesis of COPD: lessons learned from in vivo animal models.

  2007cited by this paper
• Prevalence of Alpha-1 Antitrypsin Deficiency in Poorly Controlled Asthma—Results from the ALA-ACRC Low-Dose Theophylline Trial

  2007cited by this paper
• Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.

  2007cited by this paper
• [Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency].

  2006cited by this paper
• Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno‐associated virus (rAAV1) vector

  2006cited by this paper
• Identification of a 4-mer peptide inhibitor that effectively blocks the polymerization of pathogenic Z alpha1-antitrypsin.

  2006cited by this paper
• Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

  2006cited by this paper
• Grp78, Grp94, and Grp170 interact with alpha1-antitrypsin mutants that are retained in the endoplasmic reticulum.

  2005cited by this paper
• Effects of physical activity on exercise capacity in twins with alpha-1 antitrypsin deficiency.

  2005cited by this paper
• Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response.

  2005cited by this paper
• Alpha‐1‐antitrypsin deficiency: A new paradigm for hepatocellular carcinoma in genetic liver disease

  2005cited by this paper
• A pilot study comparing the purity, functionality and isoform composition of alpha-1-proteinase inhibitor (human) products

  2005cited by this paper
• Alpha1-antitrypsin deficiency.

  2005cited by this paper
• Antibody response to aerosolized transgenic human alpha1-antitrypsin.

  2005cited by this paper
• The protease inhibitor PI*S allele and COPD: a meta-analysis

  2005cited by this paper
• Identification of a Novel Alpha1-Antitrypsin Null Variant (Q0Cairo)

  2005cited by this paper
• Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease.

  2005cited by this paper
• alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.

  2004cited by this paper
• Alpha-1-antitrypsin associated panniculitis: the MS variant.

  2004cited by this paper
• Activation of Endoplasmic Reticulum-Specific Stress Responses Associated with the Conformational Disease Z α1-Antitrypsin Deficiency1

  2004cited by this paper
• Inhibiting polymerization: new therapeutic strategies for Z alpha1-antitrypsin-related emphysema.

  2004cited by this paper
• Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.

  2004cited by this paper
• Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.

  2004cited by this paper
• Alpha-1-antitrypsin: Evidence for a fifth PI M subtype and a new deficiency allele PI*ZAugsburg

  2004cited by this paper
• α1-Antitrypsin deficiency · 1: Epidemiology of α1-antitrypsin deficiency

  2004cited by this paper
• A heat shock protein70 fusion protein with alpha1-antitrypsin in plasma of type 1 diabetic subjects.

  2004cited by this paper
• Chronic obstructive pulmonary disease in α1-antitrypsin PI MZ heterozygotes: a meta-analysis

  2004cited by this paper
• Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade.

  2003cited by this paper
• Gene Therapy Progress and Prospects: Alpha-1 antitrypsin

  2003cited by this paper
• MVarallo: A New MLike Alpha 1-Antitrypsin-Deficient Allele

  2003cited by this paper
• Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry.

  2003cited by this paper
• Enhanced proliferative effects of a baculovirus-produced fusion protein of insulin-like growth factor and alpha(1)-proteinase inhibitor and improved anti-elastase activity of the inhibitor with glutamate at position 351.

  2002cited by this paper
• Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.

  2002cited by this paper
• Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of α1–antitrypsin deficiency and the role of leukotriene B4 and interleukin 8

  2002cited by this paper
• Mode of action of RNA/DNA oligonucleotides: progress in the development of gene repair as a therapy for alpha(1)-antitrypsin deficiency.

  2002cited by this paper
• Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3' enhancer.

  2002cited by this paper
• Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.

  2002cited by this paper
• Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in 1-Antitrypsin MZ Heterozygotes: A Longitudinal Study of the General Population

  2002cited by this paper

• Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients

  2025cites this paper
• α‑1 Antitrypsin is a potential target of inflammation and immunomodulation (Review)

  2025cites this paper
• Alpha-1 Antitrypsin Deficiency Screening Using Serum Protein Electrophoresis

  2025cites this paper
• Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential

  2024cites this paper
• Hospital Admission Trends in Alpha-1-Antitrypsin Deficiency: A Sex-Based Analysis from the Spanish National Discharge Database, 2016–2022

  2024influential citation
• Characterization of three new SERPINA1 variants PiQ0Heidelberg II, PiQ0Heidelberg III and PiQ0Heidelberg IV in patients with severe alpha-1 antitrypsin deficiency.

  2023cites this paper
• Molecular changes underlying pulmonary emphysema and chronic bronchitis in Chronic Obstructive Pulmonary Disease: An updated review.

  2023cites this paper
• Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature

  2023cites this paper
• SERPINA11 related novel serpinopathy – A perinatal lethal disorder

  2023cites this paper
• Liver organoids: established tools for disease modeling and drug development

  2023cites this paper
• Overview of Recombinant Biopharmaceutical Development Using the Milk of Transgenic Livestock

  2022cites this paper
• Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil

  2021cites this paper
• Immunological aspects of Alpha 1 Antitrypsin in COVID-19 infection among the Populace and Pregnant Women

  2021cites this paper
• In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment

  2021cites this paper
• Alpha‐1‐antitrypsin: A possible host protective factor against Covid‐19

  2020cites this paper
• Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein

  2020cites this paper
• Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants

  2020cites this paper
• An Armor Against Covid-19, Could Alpha 1 Antitrypsin Be The One?

  2020cites this paper
• Alpha-1 Antitrypsin Deficiency and Pregnancy

  2020cites this paper
• Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach

  2020cites this paper
• Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy

  2020cites this paper
• Identification of Novel Proteins Interacting with Proprotein Convertase Subtilisin/Kexin 9

  2020cites this paper
• A Data-Driven Approach to Carrier Screening for Common Recessive Diseases

  2020cites this paper
• Alpha-1 Antitrypsin Replacement in Patients With COPD.

  2019cites this paper
• In vitro and in vivo translational models for rare liver diseases.

  2019cites this paper
• Letter: unlikely liver bedfellows—alpha‐1 antitrypsin deficiency and granulomatosis with polyangiitis

  2018cites this paper
• Human alpha 1-antitrypsin protects neurons and glial cells against oxygen and glucose deprivation through inhibition of interleukins expression.

  2018cites this paper
• Letter: direct‐acting anti‐viral (DAA) therapy needs strong safety and efficacy check

  2018cites this paper
• Oxidative, inflammatory, genetic, and epigenetic biomarkers associated with chronic obstructive pulmonary disorder

  2018cites this paper
• Should Serum Protein Electrophoresis Be a Surrogate for Liver Biopsy in Some Cases of Alpha1 Antitrypsin Deficiency?

  2017cites this paper
• Anti-inflammatory activity of a thermophilic serine protease inhibitor from extremophile Pyrobaculum neutrophilum

  2017cites this paper
• The alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis

  year unknowncites this paper